Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity

Daiki Tohma; Shigeru Tajima; Fumihiro Kato; Hirotaka Sato; Michinori Kakisaka; Takayuki Hishiki; Michiyo Kataoka; Haruko Takeyama; Chang-Kweng Lim; Yoko Aida; Masayuki Saijo

doi:10.1007/s00705-018-4107-0

Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity

Arch Virol. 2019 Jan;164(1):235. doi: 10.1007/s00705-018-4107-0.

Authors

Daiki Tohma^{1

2}, Shigeru Tajima³, Fumihiro Kato¹, Hirotaka Sato^{4

5}, Michinori Kakisaka⁵, Takayuki Hishiki⁶, Michiyo Kataoka⁷, Haruko Takeyama², Chang-Kweng Lim¹, Yoko Aida^{4

5}, Masayuki Saijo¹

Affiliations

¹ Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan.
² Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, 2-2 Wakamatsucho, Shinjuku, Tokyo, 162-8480, Japan.
³ Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan. stajima@nih.go.jp.
⁴ Nano Medical Engineering Laboratory, RIKEN Cluster for Pioneering Research, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
⁵ Virus Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
⁶ Department of Microbiology, Kanagawa Prefectural Institute of Public Health, 1-3-1 Shimomachiya, Chigasaki, Kanagawa, 253-0087, Japan.
⁷ Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan.

PMID: 30474754
DOI: 10.1007/s00705-018-4107-0

Abstract

We would like to correct the information on the antibody used in this study. In Fig. 5 of the article, cellular β-actin was detected as an internal control using anti-β-actin antibody (Fujifilm Wako Pure Chemicals, #017-24573).

Publication types

Published Erratum